AU Patent

AU2012200538A1 — Tumor necrosis factor inhibitors

Assigned to University of Pennsylvania Penn · Expires 2012-02-23 · 14y expired

What this patent protects

The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-a mediated conditions.

USPTO Abstract

The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-a mediated conditions.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012200538A1
Jurisdiction
AU
Classification
—
Expires
2012-02-23
Drug substance claim
No
Drug product claim
No
Assignee
University of Pennsylvania Penn
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.